Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Graham

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Plos Neglected Tropical Diseases|April 18, 2020
Gender norms and mass deworming program access in Comé, Benin: A qualitative assessment of gender-associated opportunities and challenges to achieving high mass drug administration coverageRachel E Geyer, Moudachirou Ibikounlé, Mira Emmanuel-Fabula, et al.
The Journal of General Virology|October 2, 2009
Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core proteinAllan G N Angus, David Dalrymple, Steeve Boulant, et al.
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Health Research Policy and Systems|May 29, 2016
Public/community engagement in health research with men who have sex with men in sub-Saharan Africa: challenges and opportunitiesSassy Molyneux, Salla Sariola, Dan Allman, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 11, 2014
Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialPatrick M Pullicino, Min Qian, Ralph L Sacco, et al.
Frontiers in Psychiatry|July 9, 2021
Cross-Sectional Study Protocol for the COVID-19 Impact Survey of Mothers and Their 7-11 Year Old Children in Alberta, CanadaNicole Letourneau, Sheila McDonald, Lyndsay Jerusha MacKay, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 8, 2013
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trialPatrick M Pullicino, John L P Thompson, Ralph L Sacco, et al.
International Journal of Cardiology|December 3, 2014
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trialJonathan A Shaffer, John L P Thompson, Bin Cheng, et al.
JACC. Heart Failure|August 5, 2017
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF TrialJohn R Teerlink, Min Qian, Natalie A Bello, et al.
Stroke|June 30, 2016
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction TrialMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Plos Neglected Tropical Diseases|April 18, 2020
Gender norms and mass deworming program access in Comé, Benin: A qualitative assessment of gender-associated opportunities and challenges to achieving high mass drug administration coverageRachel E Geyer, Moudachirou Ibikounlé, Mira Emmanuel-Fabula, et al.
The Journal of General Virology|October 2, 2009
Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core proteinAllan G N Angus, David Dalrymple, Steeve Boulant, et al.
European Journal of Clinical Investigation|February 26, 2019
Pulse pressure and prognosis in patients with heart failure with reduced ejection fractionNeeraj Shah, Min Qian, Marco R Di Tullio, et al.
Health Research Policy and Systems|May 29, 2016
Public/community engagement in health research with men who have sex with men in sub-Saharan Africa: challenges and opportunitiesSassy Molyneux, Salla Sariola, Dan Allman, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 11, 2014
Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialPatrick M Pullicino, Min Qian, Ralph L Sacco, et al.
Frontiers in Psychiatry|July 9, 2021
Cross-Sectional Study Protocol for the COVID-19 Impact Survey of Mothers and Their 7-11 Year Old Children in Alberta, CanadaNicole Letourneau, Sheila McDonald, Lyndsay Jerusha MacKay, et al.
Cerebrovascular Diseases (Basel, Switzerland)|August 8, 2013
Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trialPatrick M Pullicino, John L P Thompson, Ralph L Sacco, et al.
International Journal of Cardiology|December 3, 2014
Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trialJonathan A Shaffer, John L P Thompson, Bin Cheng, et al.
JACC. Heart Failure|August 5, 2017
Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF TrialJohn R Teerlink, Min Qian, Natalie A Bello, et al.
Stroke|June 30, 2016
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction TrialMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Pageof 8